Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEDIPASVIR\SOFOSBUVIR vs LERCANIDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEDIPASVIR\SOFOSBUVIR vs LERCANIDIPINE: Safety Overview

Metric LEDIPASVIR\SOFOSBUVIR LERCANIDIPINE
Total FAERS Reports 23,616 3,767
Deaths Reported 1,371 248
Death Rate 5.8% 6.6%
Hospitalizations 4,031 2,249
Average Patient Age 57.9 yrs 65.8 yrs
% Female Patients 42.9% 47.8%